About LIFTT Venture Capital Italia

This author has not yet filled in any details.
So far LIFTT Venture Capital Italia has created 304 blog entries.

LIFTT transforms into multi-vertical venture capital

2025-06-25T15:46:35+02:0025 June 2025|

Enhances focus on four macro investment areas: Infrastructure for data revolution, Human Health & Aging, Critical Resources, and Energy Security & Industrial Automation The new strategic direction aims to increase proactivity in portfolio management through a multi-vertical focus on global trends and more effective allocation of skills, resources and investments

Interview with Tommaso Demarie, CEO of Entropica Labs

2025-05-26T15:25:40+02:0026 May 2025|

Simulating Nature to Understand it: The Grand Challenge of Quantum Computing. Tommaso Demarie, CEO Entropica Labs Tommaso Demarie was born in the capital of the world’s first and original “Silicon Valley” (which was not in California but in Canavese, in Ivrea) and is the co-founder and CEO of

Sparrow Quantum Secures €21.5 Million to Accelerate Photonic Quantum Innovation in Europe

2025-04-11T09:30:41+02:0011 April 2025|

Sparrow Quantum, a leading European supplier of photonic quantum chips, has secured €21.5 million in Series A funding to accelerate the development and commercialization of its world-leading quantum chip technology. The investment round was led by PensionDanmark, with strong backing from EIFO and Novo Holdings and additional investments from existing

Does the perfect pitch exist?

2025-02-12T13:07:30+01:005 February 2025|

The moment you step up to present a pitch is a crucial milestone for any company looking to attract investors and strategic partners. It usually lasts only a few minutes, but it can shape the company’s future for years to come. So, what makes a pitch truly successful? To answer

Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader

2025-01-28T13:27:43+01:0028 January 2025|

Advances radiopharmaceutical leadership with addition of scalable manufacturing infrastructure and end-to-end clinical development capabilities Adds OCTEVY™, a registrational-stage diagnostic asset, targeting neuroendocrine tumors that is complementary to Lantheus’ therapeutic agent, PNT2003 Expands oncology radiopharmaceutical pipeline with multiple clinical and pre-clinical theranostic pairs Company reaffirms Full-Year and Fourth Quarter, 2024 financial

Composite Research: the composite materials revolution in distribution network leak repair

2025-01-15T15:36:35+01:0015 January 2025|

Leaks in gas and water distribution networks are a significant problem worldwide, with economic, environmental, and safety implications. It is estimated that millions of kilometers of gas and water pipelines worldwide are characterized by ageing infrastructure. Analyzing data from Italgas, Italy’s main distributor, it is estimated that, in the gas

The plant protein trend: the market’s response to new dietary needs

2025-01-15T15:20:19+01:0014 January 2025|

Mega trends In recent years, we have witnessed a significant shift in consumer eating behaviors, with a growing interest in plant-based diets. This trend is fueled by increased awareness about the environmental impact of intensive livestock farming and the health benefits of plant-based diets. People are increasingly looking for sustainable and healthy alternatives

T1 Solutions cooperates with Q8 on the “Sailing for Change” Project: innovation for sustainability, maritime safety and environmental protection

2024-11-22T14:54:05+01:0022 November 2024|

Our portfolio startup T1 Solutions is taking part in Q8's "Sailing for Change" project, an initiative created to celebrate the oil company's 40th anniversary. This ambitious project, implemented with the scientific support of LifeGate, aims to improve maritime transportation safety and protect the marine environment. Over the past twenty years, regulations to

Go to Top